942492-24-2

Basic information

• Product Name: Naphthalen-1,4-iMine-9-carboxylic acid, 6-[[4-chloro-5-(trifluoroMethyl)-2-pyriMidinyl]aMino]-1,2,3,4-tetrahydro-, 1,1-diMethylethyl ester, (1S,4R)-
• Synonyms: Naphthalen-1,4-iMine-9-carboxylic acid, 6-[[4-chloro-5-(trifluoroMethyl)-2-pyriMidinyl]aMino]-1,2,3,4-tetrahydro-, 1,1-diMethylethyl ester, (1S,4R)-;Naphthalen-1,4-iMine-9-carboxylic acid, 6-[[4-chloro-5-(trifluoroMethyl)-2-pyriMidinyl]aMino]-1,2,3,4-tetrahydro-, 1,1-diMethylethyl ester, (1S,4R)-12;tert-Butyl (1S,4R)-6-((4-chloro-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1,2,3,4-tetrahydro-1,4-epiminonaphthalene-9-carboxylate
• CAS NO: 942492-24-2
• Molecular Formula: C20H20ClF3N4O2
• Molecular Weight: 440.8466096
• Mol File: 942492-24-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Naphthalen-1,4-iMine-9-carboxylic acid, 6-[[4-chloro-5-(trifluoroMethyl)-2-pyriMidinyl]aMino]-1,2,3,4-tetrahydro-, 1,1-diMethylethyl ester, (1S,4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Naphthalen-1,4-iMine-9-carboxylic acid, 6-[[4-chloro-5-(trifluoroMethyl)-2-pyriMidinyl]aMino]-1,2,3,4-tetrahydro-, 1,1-diMethylethyl ester, (1S,4R)-(942492-24-2)
• EPA Substance Registry System: Naphthalen-1,4-iMine-9-carboxylic acid, 6-[[4-chloro-5-(trifluoroMethyl)-2-pyriMidinyl]aMino]-1,2,3,4-tetrahydro-, 1,1-diMethylethyl ester, (1S,4R)-(942492-24-2)

Safety Data

• Hazardous Substances Data: 942492-24-2(Hazardous Substances Data)

Relevant articles and documents

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

The present invention relates to a compound of the formula (I), or a pharmaceutically acceptable salt thereof, wherein Ar is a group of formula (III), and R1, R2, R13, A, K, M, L1, L2, X, Y1, Y2, Q, salt thereof, wherein R1, R2, R13, A, K, L1, L2, W, X, Z1, Z2, Y1, Y2, Z1, Z2, M, Q, W, X, m, p and q are as defined herein. Such novel pyrimidine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.